Zota Health Care cash flow

·UnclassifiedChart ›

Latest FY26

Cash from operations: −₹84.4cr−₹50.0 cr in FY25
Capital spending: ₹0.0crNo figure a year before
Free cash flow: −₹84.4cr−₹50.0 cr in FY25
Cash from financing: ₹490cr+238.4% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	82.5	43.2	20.1	12.0
	—	2.9	0.6	0.3	0.0
	—	−87.0	−51.9	−12.0	−12.8
	—	−33.0	−13.3	−30.3	−5.3
	—	−19.9	−0.4	−7.2	1.1
	—	−41.1	−4.1	−6.9	−4.7
	—	62.2	8.8	38.0	21.6
	—	28.1	18.6	6.1	−8.1
	—	3.8	2.3	0.2	−0.1
Cash from operating activities
	−123	−79.8	−57.6	−16.2	−4.7
	—	−1.6	3.8	8.5	3.7
	—	−81.4	−53.8	−7.7	−1.0
	—	−8.9	−3.4	−0.9	−0.8
	—	−17.4	−10.8	−4.2	−2.5
	—	0.0	0.0	0.0	−0.5
	—	11.5	3.5	1.5	2.1
	—	−84.4	−50.0	−6.0	−2.0
Cash from investing activities
	—	0.0	0.0	0.0	12.5
	—	−113	−46.0	−16.7	1.1
	—	0.0	0.0	0.1	0.0
	—	−210	−49.7	2.8	25.3
	—	0.0	0.0	0.0	−0.0
	—	8.9	3.4	0.9	0.8
	—	0.0	0.0	0.0	0.0
	—	−314	−92.2	−12.9	14.7
Cash from financing activities
	—	586	151	20.9	0.0
	—	−43.0	37.8	5.2	0.0
	—	0.0	0.0	9.8	−1.7
	—	−23.1	9.1	0.0	0.0
	—	55.5	21.7	10.3	5.9
	—	—	—	4.2	2.5
	—	17.4	10.7	0.0	0.0
	—	3.1	2.7	2.6	3.8
	—	490	145	18.8	−13.9
	—	92.0	2.6	−0.1	−1.2
	—	0.0	0.0	0.0	−0.0
	—	92.0	2.6	−0.1	−1.2
	—	—	—	1.0	1.1
Reference items
	−0.3	18.5	−5.7	7.6	7.3
	−0.0%	3.4%	−2.0%	4.2%	5.2%
	−84.4	−84.4	−50.0	−6.0	−14.5
	—	−78.7	−69.7	−0.2	—
	−₹24.38	−₹24.38	−₹14.43	−₹1.73	−₹4.19
	—	1.14×	0.88×	0.42×	0.35×
	—	11.5	3.5	1.5	2.1
	—	17.4	10.7	0.0	0.0

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ZOTA₹1,323.60

Zota Health Care LImited

· Unclassified

₹ CrorePeersMARINE BETATHEJOMcap ₹4,584 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	12.0	20.1	43.2	82.5	—
+ Share-based Payments	0.0	0.3	0.6	2.9	—
Changes in Working Capital
+ Inventories	-12.8	-12.0	-51.9	-87.0	—
+ Trade Receivables — Current	-5.3	-30.3	-13.3	-33.0	—
+ Other Financial Assets — Current	1.1	-7.2	-0.4	-19.9	—
+ Other Current Assets	-4.7	-6.9	-4.1	-41.1	—
+ Trade Payables — Current	21.6	38.0	8.8	62.2	—
+ Other Current Liabilities	-8.1	6.1	18.6	28.1	—
+ Provisions — Non-current	-0.1	0.2	2.3	3.8	—
Cash from Operating Activities
Profit Before Tax (per I/S)	-4.7	-16.2	-57.6	-79.8	-123.1
+ Total Adjustments (incl. Working Capital)	3.7	8.5	3.8	-1.6	—
Cash from Operations (pre-tax)	-1.0	-7.7	-53.8	-81.4	—
+ Interest Received — Operating	-0.8	-0.9	-3.4	-8.9	—
+ Interest Paid — Operating	-2.5	-4.2	-10.8	-17.4	—
+ Other Inflows / (Outflows) — Operating	-0.5	0.0	0.0	0.0	—
+ Income Taxes Paid	2.1	1.5	3.5	11.5	—
Cash from Operating Activities	-2.0	-6.0	-50.0	-84.4	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	12.5	0.0	0.0	0.0	—
+ Disp of Fixed Assets	1.1	-16.7	-46.0	-112.9	—
+ Disp of Goodwill	0.0	0.1	0.0	0.0	—
+ Disp of Other Long-term Assets	25.3	2.8	-49.7	-209.5	—
+ Loans & Advances Repaid	-0.0	0.0	0.0	0.0	—
+ Interest Received — Investing	0.8	0.9	3.4	8.9	—
+ Other Inflows / (Outflows) — Investing	0.0	0.0	0.0	0.0	—
Cash from Investing Activities	14.7	-12.9	-92.2	-313.6	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	0.0	20.9	151.1	585.7	—
+ Proceeds from Other Equity Instruments	0.0	5.2	37.8	-43.0	—
+ Proceeds from Borrowings	-1.7	9.8	0.0	0.0	—
+ Repayment of Borrowings	0.0	0.0	9.1	-23.1	—
+ Payment of Lease Liabilities	5.9	10.3	21.7	55.5	—
+ Payment of Finance Lease Liabilities	2.5	4.2	—	—	—
+ Interest Paid	0.0	0.0	10.7	17.4	—
+ Dividends Paid	3.8	2.6	2.7	3.1	—
Cash from Financing Activities	-13.9	18.8	144.8	489.9	—
Net Changes in Cash (pre-FX)	-1.2	-0.1	2.6	92.0	—
+ Effect of FX Rate Changes on Cash	-0.0	0.0	0.0	0.0	—
Net Changes in Cash	-1.2	-0.1	2.6	92.0	—
Closing Cash	1.1	1.0	—	—	—
Reference Items
EBITDA	7.3	7.6	-5.7	18.5	-0.3
EBITDA Margin %	5.24	4.19	-1.96	3.44	-0.04
Free Cash Flow (CFO − Capex)	-14.5	-6.0	-50.0	-84.4	-84.4
Free Cash Flow to Equity	—	-0.2	-69.7	-78.7	—
Free Cash Flow per Basic Share	-4.19	-1.73	-14.43	-24.38	-24.38
Cash Flow to Net Income	0.35	0.42	0.88	1.14	—
Cash Paid for Taxes	2.1	1.5	3.5	11.5	—
Cash Paid for Interest	0.0	0.0	10.7	17.4	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.